AR034355A1
Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester
Abstract
This refers to a pharmaceutical composition comprising a lipase inhibitor, preferably orlistat, with a melting point> = 37 ° C, a sucrose fatty acid ester wherein the sucrose acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
65 members in 40 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 01113793 | European Patent Office (EPO) | A | |
| 01113793 | European Patent Office (EPO) | A | |
| 011137932 | – | – | – |
| EP20010113793 | – | – | – |
Members65
| Document | Office | Kind | |
|---|---|---|---|
| CA2448030A1 | Canada | A1 | |
| WO02098412A1 | World Intellectual Property Organization (WIPO) | A1 | |
| PA8546701A1 | Panama | A1 | |
| US2003027786A1 | United States of America | A1 | |
| GT200200106A | Guatemala | A | |
| PE20030230A1 | Peru | A1 | |
| NO20035318D0 | Norway | D0 | |
| ECSP034871A | Ecuador | A | |
| KR20040010689A | Republic of Korea | A | |
| AR034355A1This record | Argentina | A1 | |
| MXPA03011191A | Mexico | A | |
| EP1399152A1 | European Patent Office (EPO) | A1 | |
| CZ20033525A3 | Czechia | A3 | |
| SK16092003A3 | Slovakia | A3 | |
| IL158908D0 | Israel | D0 | |
| BR0210266A | Brazil | A | |
| CN1514725A | China | A | |
| JP2004532271A | Japan | A | |
| HU0401208A2 | Hungary | A2 | |
| MA27031A1 | Morocco | A1 | |
| PL366890A1 | Poland | A1 | |
| BG108421A | Bulgaria | A | |
| HK1067312A1 | Hong Kong, China | A1 | |
| ZA200309007B | South Africa | B | |
| US2005101562A1 | United States of America | A1 | |
| RU2003136728A | Russian Federation | A | |
| CO5540293A2 | Colombia | A2 | |
| AU2002257817B2 | Australia | B2 | |
| HRP20030983A2 | Croatia | A2 | |
| RU2271808C2 | Russian Federation | C2 | |
| NZ529630A | New Zealand | A | |
| RS96003A | Serbia | A | |
| EP1399152B1 | European Patent Office (EPO) | B1 | |
| AT356622T | Austria | T | |
| DE60218845D1 | Germany | D1 | |
| PT1399152E | Portugal | E | |
| DK1399152T3 | Denmark | T3 | |
| KR100753729B1 | Republic of Korea | B1 | |
| SI1399152T1 | Slovenia | T1 | |
| ES2282415T3 | Spain | T3 | |
| DE60218845T2 | Germany | T2 | |
| HU0401208A3 | Hungary | A3 | |
| IL158908A | Israel | A | |
| JO2455B1 | Jordan | B1 | |
| CZ299948B6 | Czechia | B6 | |
| JP4261337B2 | Japan | B2 | |
| JP2009108076A | Japan | A | |
| NO328006B1 | Norway | B1 | |
| CA2448030C | Canada | C | |
| CN1514725B | China | B | |
| RS50713B | Serbia | B | |
| SK287602B6 | Slovakia | B6 | |
| US8039508B2 | United States of America | B2 | |
| HRP20030983B1 | Croatia | B1 | |
| US2011301231A1 | United States of America | A1 | |
| ME00579A | Montenegro | A | |
| ME00579B | Montenegro | B | |
| US8343543B2 | United States of America | B2 | |
| US2013079391A1 | United States of America | A1 | |
| CY1107641T1 | Cyprus | T1 | |
| BG66346B1 | Bulgaria | B1 | |
| PL215266B1 | Poland | B1 | |
| BRPI0210266B1 | Brazil | B1 | |
| HU230405B1 | Hungary | B1 | |
| MY161871A | Malaysia | A |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| RefusalFC | FC |
Numbers
- Publication, DOCDB
- 034355
- Publication, EPODOC
- AR034355
- Application
- 102074
- Application, DOCDB
- P020102074
- Application, EPODOC
- AR2002P102074
Titles2
- Spanish
- NUEVA COMPOSICION FARMACEUTICA
- English
- NEW PHARMACEUTICAL COMPOSITION
Classification
- CPC, 9
- A61K47/26
- A61K9/0056
- A61K31/365
- A61P3/00
- A61P3/10
- A61P3/04
- A61P3/06
- A61P43/00
- A61K31/335
- IPC, 15
- A61K47 02
- A61K9 00
- A61K9 20
- A61K31 337
- A61K31 365
- A61K31 7024
- A61K45 00
- A61K47 10
- A61K47 24
- A61K47 26
- A61K47 32
- A61K47 34
- A61K47 38
- A61P3 04
- A61P43 00